Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Oct 16;16(20):3499.
doi: 10.3390/cancers16203499.

Quantitative Multi-Parametric MRI of the Prostate Reveals Racial Differences

Affiliations

Quantitative Multi-Parametric MRI of the Prostate Reveals Racial Differences

Aritrick Chatterjee et al. Cancers (Basel). .

Abstract

Purpose: This study investigates whether quantitative MRI and histology of the prostate reveal differences between races, specifically African Americans (AAs) and Caucasian Americans (CAs), that can affect diagnosis. Materials and Methods: Patients (98 CAs, 47 AAs) with known or suspected prostate cancer (PCa) underwent 3T MRI (T2W, DWI, and DCE-MRI) prior to biopsy or prostatectomy. Quantitative mpMRI metrics: ADC, T2, and DCE empirical mathematical model parameters were calculated. Results: AAs had a greater percentage of higher Gleason-grade lesions compared to CAs. There were no significant differences in the quantitative ADC and T2 values between AAs and CAs. The cancer signal enhancement rate (α) on DCE-MRI was significantly higher for AAs compared to CAs (AAs: 13.3 ± 9.3 vs. CAs: 6.1 ± 4.7 s-1, p < 0.001). The DCE signal washout rate (β) was significantly lower in benign tissue of AAs (AAs: 0.01 ± 0.09 s-1 vs. CAs: 0.07 ± 0.07 s-1, p < 0.001) and significantly elevated in cancer tissue in AAs (AAs: 0.12 ± 0.07 s-1 vs. CAs: 0.07 ± 0.08 s-1, p = 0.02). DCE significantly improves the differentiation of PCa from benign in AAs (α: 52%, β: 62% more effective in AAs compared to CAs). Histologic analysis showed cancers have a greater proportion (p = 0.04) of epithelium (50.9 ± 12.3 vs. 44.7 ± 12.8%) and lower lumen (10.5 ± 6.9 vs. 16.2 ± 6.8%) in CAs compared to AAs. Conclusions: This study shows that AAs have different quantitative DCE-MRI values for benign prostate and prostate cancer and different histologic makeup in PCa compared to CAs. Quantitative DCE-MRI can significantly improve the performance of MRI for PCa diagnosis in African Americans but is much less effective for Caucasian Americans.

Keywords: African Americans; Caucasian Americans; DCE-MRI; MRI; prostate cancer; quantitative; racial differences.

PubMed Disclaimer

Conflict of interest statement

The authors state that they have no conflicts of interest related to the material discussed in this article. Drs. Chatterjee, Oto, and Karczmar have equity in QMIS, LLC, which is unrelated to this study.

Figures

Figure 1
Figure 1
52-year-old African American patient with Gleason 4 + 3 cancer in the left apex in the peripheral zone (red arrows on MRI). The lesion is seen as a hypo-intense region on the T2W image, T2 (87.9 ± 16.4 ms), and mildly hypo-intense on ADC (1.32 ± 0.20 µm2/ms) maps with early focal enhancement on DCE-MRI, evidenced by high signal enhancement rate (19.3 s−1) and rapid washout rate (0.07 s−1). Surrounding benign tissue in the peripheral zone had ADC = 2.05 ± 0.10 µm2/ms, T2 = 308.9 ± 62.6 ms, α = 2.87 s−1, and β = 0.04 s−1. Another relevant finding is the presence of Gleason 3 + 3 cancers in the right apex. Cancers are outlined in blue on histology sections.
Figure 2
Figure 2
52-year-old Caucasian American patient with Gleason 3 + 4 cancer in the right apex in the peripheral zone (red arrows on mpMRI). The lesion is seen as a hypo-intense region on the T2W image, T2 (112.4 ± 54.6 ms), and mildly hypo-intense on ADC (0.86 ± 0.12 µm2/ms) maps with only diffuse early enhancement on DCE-MRI, evidenced by low signal enhancement rate (3.50 s−1) and washout rate (0.03 s−1). Surrounding benign tissue in the peripheral zone had ADC = 1.16 ± 0.19 µm2/ms, T2 = 125.1 ± 34.5 ms, α = 3.20 s−1, and β = 0.01 s−1. Cancers are outlined in blue on histology sections.

Similar articles

Cited by

References

    1. Siegel R.L., Giaquinto A.N., Jemal A. Cancer statistics, 2024. CA A Cancer J. Clin. 2024;74:12–49. doi: 10.3322/caac.21820. - DOI - PubMed
    1. Sung H., Ferlay J., Siegel R.L., Laversanne M., Soerjomataram I., Jemal A., Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA A Cancer J. Clin. 2021;71:209–249. doi: 10.3322/caac.21660. - DOI - PubMed
    1. American Cancer Society Key Statistics for Prostate Cancer. [(accessed on 9 April 2024)]. Available online: https://www.cancer.org/cancer/types/prostate-cancer/about/key-statistics....
    1. Mahal B.A., Alshalalfa M., Spratt D.E., Davicioni E., Zhao S.G., Feng F.Y., Rebbeck T.R., Nguyen P.L., Huang F.W. Prostate Cancer Genomic-risk Differences Between African-American and White Men Across Gleason Scores. Eur. Urol. 2019;75:1038–1040. doi: 10.1016/j.eururo.2019.01.010. - DOI - PubMed
    1. Mahal B.A., Berman R.A., Taplin M.-E., Huang F.W. Prostate Cancer–Specific Mortality Across Gleason Scores in Black vs Nonblack MenProstate Cancer–Specific Mortality Across Gleason Scores in Black and Nonblack MenLetters. JAMA. 2018;320:2479–2481. doi: 10.1001/jama.2018.11716. - DOI - PubMed

LinkOut - more resources